CLOs on the Move

Gift of Hope

www.giftofhope.org

 
Gift of Hope Organ & Tissue Donor Network is a not-for-profit organ procurement organization that coordinates organ and tissue donation and provides public education on donation in Illinois and northwest Indiana. As one of 58 OPOs that make up the nation’s donation system, we work with 180 hospitals and serve 12 million people in our donation service area. Since 1986, we have saved the lives of more than 23,000 organ transplant recipients and improved the lives of hundreds of thousands of tissue transplant recipients through our efforts.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Henry County Medical Center

Located in Paris, TN, Henry County Medical Center is a progressive, integrated healthcare organization committed to serving the healthcare needs of Henry County and the adjoining region. Including a 142-bed hospital and other facilities, the medical center provides a variety of outpatient services, as well as inpatient care. Additionally, HCMC owns and operates 8 provider clinics in various specialties. Henry County Medical Center is a county-owned and operated nonprofit institution.

Nashville Anesthesia Service

Nashville Anesthesia Service is a Madison, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medica HealthCare Plans

Medica HealthCare Plans is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rush-Copley Medical Center, Inc

Rush-Copley Medical Center, Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Aurora, IL. To find more information about Rush-Copley Medical Center, Inc, please visit www.rushcopley.com

Catabasis

At Catabasis Pharmaceuticals, our mission is to bring hope and life-changing therapies to patients and their families. Our SMART (Safely Metabolized And Rationally Targeted) Linker drug discovery platform enables us to engineer molecules that simultaneously modulate multiple targets in a disease. We are applying our SMART LinkerSM platform to build an internal pipeline of product candidates for rare diseases and plan to pursue partnerships to develop additional product candidates.